Orange Book product · Brand (NDA)
LIPOSYN III 30%
SOYBEAN OIL
At a glance
Jan 13, 1998
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 13, 1998
28 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
SOYBEAN OIL
Strength
30%
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 020181
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1996INTRALIPID 20%Brand (NDA)
NDA 020248 · FRESENIUS
- 1993INTRALIPID 30%Brand (NDA)
NDA 019942 · FRESENIUS
- 1993NUTRILIPID 10%Brand (NDA)
NDA 019531 · B BRAUN
- 1984LIPOSYN III 20%Brand (NDA)
NDA 018970 · HOSPIRA
- 1984LIPOSYN III 10%Brand (NDA)
NDA 018969 · HOSPIRA
- 1983SOYACAL 10%Brand (NDA)
NDA 018465 · ALPHA THERA
- 1983SOYACAL 20%Brand (NDA)
NDA 018786 · ALPHA THERA
- 1983TRAVAMULSION 20%Brand (NDA)
NDA 018758 · BAXTER HLTHCARE
- 1982TRAVAMULSION 10%Brand (NDA)
NDA 018660 · BAXTER HLTHCARE
- —INTRALIPID 10%Brand (NDA)
NDA 017643 · FRESENIUS
- —INTRALIPID 20%Brand (NDA)
NDA 018449 · FRESENIUS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
